These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23392461)

  • 41. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
    Myers ER; Thompson JW; Simpson K
    Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of HIV screening of blood transfusions in Zambia.
    Foster S; Buvé A
    Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings.
    Ishikawa N; Dalal S; Johnson C; Hogan DR; Shimbo T; Shaffer N; Pendse RN; Lo YR; Ghidinelli MN; Baggaley R
    J Int AIDS Soc; 2016; 19(1):21212. PubMed ID: 27978939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda.
    Kuznik A; Lamorde M; Hermans S; Castelnuovo B; Auerbach B; Semeere A; Sempa J; Ssennono M; Ssewankambo F; Manabe YC
    Bull World Health Organ; 2012 Aug; 90(8):595-603. PubMed ID: 22893743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
    Karnon J; Orji N
    Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi.
    Orlando S; Marazzi MC; Mancinelli S; Liotta G; Ceffa S; Giglio P; Alumando E; Ziegler I; Shawa M; Palombi L
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):631-4. PubMed ID: 21934555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.
    Juusola JL; Brandeau ML; Long EF; Owens DK; Bendavid E
    AIDS; 2011 Sep; 25(14):1779-87. PubMed ID: 21716076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The time to recommend antenatal HIV screening for all pregnant women has arrived.
    Ziegler JB; Graves N
    Med J Aust; 2004 Aug; 181(3):124-5. PubMed ID: 15287826
    [No Abstract]   [Full Text] [Related]  

  • 55. Active pediatric HIV case finding in Kenya and Uganda: A look at missed opportunities along the prevention of mother-to-child transmission of HIV (PMTCT) cascade.
    Gill MM; Natumanya EK; Hoffman HJ; Okomo G; Taasi G; Guay L; Masaba R
    PLoS One; 2020; 15(6):e0233590. PubMed ID: 32484815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Saba J
    AIDS; 1998 May; 12(8):939-48. PubMed ID: 9631148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Missed opportunities for congenital syphilis and HIV perinatal transmission prevention.
    Rodrigues CS; Guimarães MD; César CC
    Rev Saude Publica; 2008 Oct; 42(5):851-8. PubMed ID: 18833384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing stakeholder perceptions of the acceptability and feasibility of national scale-up for a dual HIV/syphilis rapid diagnostic test in Malawi.
    Maddox BLP; Wright SS; Namadingo H; Bowen VB; Chipungu GA; Kamb ML
    Sex Transm Infect; 2017 Dec; 93(S4):S59-S64. PubMed ID: 29223964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The economic profile of antenatal HIV testing: pharmaceutical and methodological considerations.
    Postma MJ; Beck EJ; Sprenger HG; de Jong-van den Berg LT
    AIDS; 2003 Mar; 17(5):755-7. PubMed ID: 12646801
    [No Abstract]   [Full Text] [Related]  

  • 60. Increasing access to prevention of mother-to-child transmission of HIV services through the private sector in Uganda.
    Mbonye AK; Hansen KS; Wamono F; Magnussen P
    Sex Transm Infect; 2009 Dec; 85(7):534-9. PubMed ID: 19703840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.